Results 141 to 150 of about 1,986,270 (196)
Some of the next articles are maybe not open access.
The Fibrinolytic Enzyme System
1983An outline of the fibrinolytic enzyme system was provided in Chapter 1. In this chapter the properties of the individual components of the system are described with an account of their interaction to culminate in the physiological dissolution of fibrin.
openaire +1 more source
RELEASE OF FIBRINOLYTIC ENZYMES FROM HUMAN CORNEA
Acta Ophthalmologica, 1972The release of fibrinolytic agents from human cornea was studied by culturing foetal corneal explants in the presence of a standard fibrin clot and measuring the fibrin degradation products formed in the culture medium. Cultures of cornea were found to invariably release a significant amount of fibrinolytic agents, probably fibrinolytic activators ...
M, Pandolfi, B, Astedt, K, Dyster-Aas
openaire +2 more sources
The fibrinolytic enzyme system in the newborn
American Journal of Obstetrics and Gynecology, 1966Abstract 1. 1. In confirmation of previous reports the plasminogen level in cord blood is shown to be low and decreases further in the first days of life. 2. 2. Plasmin, urokinase, and streptokinase inhibitor levels are in the normal adult ranges. 3. 3. Activator is present in cord blood and is considered to be responsible for spontaneous
F, Beller, G W, Douglas, M D, Epstein
openaire +2 more sources
International Journal of Biological Macromolecules, 2021
Mingyuan Lu +6 more
semanticscholar +1 more source
Mingyuan Lu +6 more
semanticscholar +1 more source
Acyl-Enzymes As Fibrinolytic Agents
Thrombosis and Haemostasis, 1981Plasminogen activators or plasmins specifically and reversibly acylated at the active centre have been used as delivery systems for fibrinolytic agents in vivo. Potential advantages of this approach, including enhanced efficacy, reduced toxicity and better control of lysis are discussed.
openaire +1 more source
Angiotensin-converting enzyme inhibition and fibrinolytic balance
Hypertension Research, 2011Fibrinolytic activity is primarily determined by the balance between the levels of tissue plasminogen activator (t-PA) and plasminogen activator inhibitor type 1 (PAI-1).1 Impaired fibrinolytic function, characterized by increased PAI-1 level and decreased t-PA activity, has been found in patients with hypertension.
MATSUMOTO, Tetsuya, HORIE, Minoru
openaire +3 more sources
Patented Fibrinolytic Enzymes: An Overview
Recent Patents on BiotechnologyAbstract: Fibrinolytic enzymes have garnered significant attention from researchers due to their immense potential in the medical field. As research continues to advance, the outcomes have become increasingly fruitful. The generation of applicable knowledge is usually accompanied by its protection through patent
Yuan Cao +4 more
openaire +1 more source
Metal–Organic Framework-Based Enzyme Biocomposites
Chemical Reviews, 2021, Peter Wied, Francesco Carraro
exaly
Chemistry of Thrombolysis: Human Fibrinolytic Enzymes.
Archives of Internal Medicine, 1964Human thrombotic disease ranks among the leading causes of death in modern civilized society, and any measure which can help to reduce mortality and morbidity from this cause would be of inestimable value. It is only in recent years that the possibility of the successful dissolution of human thrombi or emboli by the use of fibrinolytic enzymes has been
openaire +1 more source
Bioinspired Framework Catalysts: From Enzyme Immobilization to Biomimetic Catalysis
Chemical Reviews, 2023Kun-Yu Wang, Jiandong Pang, Wei Shi
exaly